GLP-1 Weight Loss and Diabetes Drugs Look Safe for People Battling Opioid Addiction
If you have paid attention to health news lately, you know GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have blown up in popularity. But for a long time, doctors were a bit hesitant to prescribe them to people struggling with opioid use disorder. Medical trials almost always leave people with active substance use out of their studies, which left doctors in the dark about potential side effects.
A recent study just changed that, and the takeaway is really reassuring. These popular medications do not appear to carry extra health risks for people managing opioid addiction.
To get these answers, researchers dug through real-world health insurance data, tracking thousands of patients with opioid use disorder who started taking a GLP-1 for diabetes or weight management. They closely monitored ten specific physical and mental health issues, ranging from severe stomach problems and kidney damage to anxiety, depression, and suicidal thoughts.
Across the board, the results brought good news. GLP-1s showed no increased risk of physical or emotional harm. In fact, patients on these medications actually had a thirty-five percent lower risk of developing pancreatitis compared to those not taking them. Despite common concerns about GLP-1s slowing down digestion, there was no added risk of severe stomach issues or kidney problems. On top of that, patients on the drugs reported lower rates of anxiety and fewer trouble-sleeping nights.
This is a big deal for patient care. When someone is in recovery for opioid addiction, doctors have to be extra cautious with new prescriptions, fearing that side effects like stomach discomfort or mood swings might destabilize a patient. This research gives clinicians the confidence to safely treat conditions like type 2 diabetes and obesity in this population.
Keep in mind, this study focused purely on whether GLP-1s are safe to take for metabolic health. It did not test whether these medications can actually help treat opioid addiction itself, though scientists are actively researching that possibility right now.
